跳至主要内容
临床试验/NCT00600431
NCT00600431已完成不适用

Melanocytic-Nevi-Counts During Chemotherapy of Children With Malignancies.

Medical University of Graz1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2006年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
32
试验地点
1
主要终点
total body nevus count

研究概览

简要总结

Changes in nevus count in 16 children (8m, 8f) aged between 2 and 17 years (median:8 years) suffering from different malignancies were examined every three months during a one-year period after starting chemotherapy. An age and sex matched control group underwent the same skin examinations.At the start of our study, the range of number of nevi in the chemotherapy group was 0-133, in the control group 2-199.

详细描述

Objectives:

Patients given chemotherapy because of different malignancies have an increased susceptibility to cutaneous tumours and infection and a change of number of nevi during treatment is discussed. We investigated wether total nevi count changes in children undergoing chemotherapy. Therefore 16 (8m, 8f) children suffering from leukaemia (11), lymphoma (2), adenosarcoma of the kidney (1), Ewing´s sarcoma (1) and neuroblastoma (1) aged between 2 and 17 years (median:8 years), under chemotherapy at the pediatric department of oncology, were examined at the beginning and 9-12 months after starting chemotherapy. As control group age and sex matched children of the local population were used.

Materials and Methods:

At the beginning of chemotherapy the nevi were counted on the total body. All nevi were larger in diameter than 1mm and as melanocytic lesion identifiable. Clinical and dermoscopic photographs were taken of every nevus. If the patient had more than 50 nevi, only nevi on the face, right arm, upper back and the buttocks were documented. Reassessment was repeated every 3 month.

Conclusion:

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patient and/or parents willing to participate in the study
  • Age under 18
  • Study Group Only:
  • Patient suffering from a malignancy requiring systemic chemotherapy

排除标准

  • Patient and/or parents who decline to participate in the study

结局指标

主要结局

total body nevus count

时间窗: Every three months during a one year period

次要结局

未报告次要终点

研究者

发起方
Medical University of Graz
申办方类型
Other

研究点 (1)

Loading locations...

相似试验